信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·股票行情快报：百诚医药（301096）4月10日主力资金净买入55.96万元2023-4-10 22:13:56
·股票行情快报：奇正藏药（002287）4月10日主力资金净卖出302.57万元2023-4-10 21:15:20
·东北制药：普瑞巴林原料药上市申请获得批准2023-4-10 18:25:36
·份额创新高！医药主题ETF王者归来？医药板块或由量变转向质变2023-4-10 18:07:48
·百利天恒：创新生物药产品均处于临床试验阶段存在较高不确定性2023-4-10 17:59:57
·国君策略：一季报结构性亮点在受益内需修复的消费、医药、制造等传统成长细分领域2023-4-10 13:46:54
·龙津药业控股股东再减持2403万股无创新药掣肘业绩增长2023-4-10 10:32:00
·本周A股限售股解禁市值超660亿元，一汽解放、罗欣药业、铭利达、爱尔眼科、京东方A等解禁规模靠前2023-4-10 8:16:41
·国邦医药2022年度净利9.21亿同比增长30.43%销量增长明显2023-4-10 1:16:22
·济川药业2022年净利21.71亿同比增长26.27%董事长曹龙祥薪酬375万2023-4-10 0:32:30
·华仁药业2023年第一季度预计净利3500万-4500万同比增长39.78%-79.72%2023-4-9 23:16:08
·林园最新闭门私享：投资就是要把全世界最好的东西抓一个放进口袋，不要过多担心泡沫！医药股现在并没有被高2023-4-9 10:17:47
·这地奥司他韦又紧俏：药店称经销商大幅加价还要求“配货”2023-4-8 11:45:35
·美得州法官称将暂停口服堕胎药米非司酮的销售批准2023-4-8 11:35:21
·透视医药集采成效：累计降低药耗费用超4000亿元2023-4-8 8:10:34
·山河药辅2023年第一季度预计净利4741万-5141万同比增长40%-52%外贸业务保持较快增长2023-4-8 7:24:39
·山河药辅2022年净利1.31亿同比增长46.45%董事长尹正龙薪酬82.38万2023-4-8 7:16:32
·恒道医药董事会秘书陶义华辞职王长浩接任2023-4-7 22:03:56
·千亿白马涨近7%！医药赛道热度大增业绩线催动行情这些细分方向或可关注2023-4-7 17:59:21
·联环药业：收到药品GMP符合性检查结果2023-4-7 17:26:41

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]